The RBM Partnership’s Advocacy and Resource Mobilisation Partner Committee (ARMPC) includes a dedicated workstream on Innovation and Access (I&A) which aims to sustain and increase cross-sectoral support for investing in malaria innovations, creating demand for the most effective innovations, and supporting scale-up of innovations for the populations most in need of accessing them.
The I&A workstream has finalized two pieces of qualitative research to capture country-level perspectives on innovation and access challenges from a broad range of stakeholders. One research work included 42 in-depth interviews with key informants from 14 malaria endemic countries; the other research focused exclusively on Nigeria, involving 102 responses from an online survey and 23 key informant interviews. Among the recommendations advanced by key informants, include requests to:
● Optimize access by strengthening existing systems
● Increase acceptance of innovations through multisectoral engagement
● Strengthen national R&D and manufacturing capacity to address local needs
● Diversify source of financing for innovation The main objective of this consultancy is to advance these recommendations from malaria endemic country stakeholders.
The Supplier/s will be responsible for the delivery of these expected outputs:
Lot 1:
1.1 Stakeholder mapping with select key informant interviews (15 March 2021)
1.2 Delivery of a 2-year calendar of potential events in which I&A recommendations could feature (31 March 2021)
1.3 Final summary report (31 March 2021)
Lot 2:
2.1 Communication tools to support advocacy for I&A recommendations (31 March 2021)
2.2 Preparation support for 2 events (Depends on date of events, no later than 15 Oct 2021)
2.3 Final summary report (30 Oct 2021)
